Personal information

Activities

Works (5)

A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203)

ESMO Open
2024-03 | Journal article
Contributors: A.M. Di Giacomo; M. Schenker; J. Medioni; S. Mandziuk; M. Majem; G. Gravis; M. Cornfeld; S. Ranganathan; S. Lou; T. Csoszi
Source: check_circle
Crossref

From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma

OncoTargets and Therapy
2023-04 | Journal article
Contributors: Elena Simonetti; Serena Cutarella; Monica Valente; Tommaso Sani; Matteo Ravara; Michele Maio; Anna Maria Di Giacomo
Source: check_circle
Crossref

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

Viruses
2023-02 | Journal article | Author
Contributors: MARIA GRAZIA CUSI; Anna Maria Di Giacomo; Gabriele Anichini; Gianni Gori Savellini; Chiara Terrosi; Claudia Gandolfo; Michele Maio
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immunotherapy for brain metastases and primary brain tumors

European Journal of Cancer
2023-01 | Journal article
Contributors: Anna M. Di Giacomo; Maximilian J. Mair; Michele Ceccarelli; Andrea Anichini; Ramy Ibrahim; Michael Weller; Michael Lahn; Alexander M.M. Eggermont; Bernard Fox; Michele Maio
Source: check_circle
Crossref

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines

European Journal of Cancer
2022-08 | Journal article
Contributors: Anna M. Di Giacomo; Gianluca Giacobini; Gabriele Anichini; Claudia Gandolfo; Vincenzo D'alonzo; Luana CalabrĂ²; Maria F. Lofiego; Maria G. Cusi; Michele Maio
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for European journal of cancer. (1)